339 related articles for article (PubMed ID: 8365305)
21. Protein C and S deficiency in severe infectious purpura of children: a collaborative study of 40 cases.
Leclerc F; Hazelzet J; Jude B; Hofhuis W; Hue V; Martinot A; Van der Voort E
Intensive Care Med; 1992; 18(4):202-5. PubMed ID: 1430582
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of Disseminated Intravascular Coagulation in Critically Ill Pediatric Hemato-oncology Patients with Septic Shock.
Jhang WK; Park SJ
Thromb Haemost; 2020 Nov; 120(11):1505-1511. PubMed ID: 32772349
[TBL] [Abstract][Full Text] [Related]
23. Coagulation inhibitors in sepsis and disseminated intravascular coagulation.
Lee WL; Downey GP
Intensive Care Med; 2000 Nov; 26(11):1701-6. PubMed ID: 11193281
[TBL] [Abstract][Full Text] [Related]
24. The initial experience of antithrombin III in the management of neonates with necrotizing enterocolitis.
St Peter SD; Little DC; Calkins CM; Holcomb GW; Snyder CL; Ostlie DJ
J Pediatr Surg; 2007 Apr; 42(4):704-8. PubMed ID: 17448770
[TBL] [Abstract][Full Text] [Related]
25. [Use of antithrombin III concentrates].
Vinazzer H
Beitr Infusionsther; 1989; 24():151-8. PubMed ID: 2481532
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of antithrombin III supplementation in animal models of fulminant Escherichia coli endotoxemia or bacteremia.
Emerson TE; Fournel MA; Redens TB; Taylor FB
Am J Med; 1989 Sep; 87(3B):27S-33S. PubMed ID: 2679067
[TBL] [Abstract][Full Text] [Related]
27. Effective combination therapy of polymyxin-B direct hemoperfusion and recombinant thrombomodulin for septic shock accompanied by disseminated intravascular coagulation: a historical controlled trial.
Yamato M; Minematsu Y; Fujii J; Mori K; Minato T; Miyagawa S; Fujimura R; Morikage N; Arata Y; Nakano C; Wada A; Ito T
Ther Apher Dial; 2013 Oct; 17(5):472-6. PubMed ID: 24107274
[TBL] [Abstract][Full Text] [Related]
28. Effect of antithrombin III among patients with disseminated intravascular coagulation in obstetrics: a nationwide observational study in Japan.
Iwasaki Y; Ohbe H; Shigemi D; Fushimi K; Yasunaga H
BJOG; 2022 Apr; 129(5):805-811. PubMed ID: 34545675
[TBL] [Abstract][Full Text] [Related]
29. International Society on Thrombosis and Haemostasis score for overt disseminated intravascular coagulation predicts organ dysfunction and fatality in sepsis patients.
Voves C; Wuillemin WA; Zeerleder S
Blood Coagul Fibrinolysis; 2006 Sep; 17(6):445-51. PubMed ID: 16905947
[TBL] [Abstract][Full Text] [Related]
30. Can recombinant human thrombomodulin increase survival among patients with severe septic-induced disseminated intravascular coagulation: a single-centre, open-label, randomised controlled trial.
Hagiwara A; Tanaka N; Uemura T; Matsuda W; Kimura A
BMJ Open; 2016 Dec; 6(12):e012850. PubMed ID: 28039291
[TBL] [Abstract][Full Text] [Related]
31. [Therapy of disseminated intravascular coagulation in acute promyelocytic leukemias. Apropos of 19 cases].
Rodríguez Gómez M; López Fernández MF; Batlle J
Sangre (Barc); 1993 Dec; 38(6):449-53. PubMed ID: 8171380
[TBL] [Abstract][Full Text] [Related]
32. [Effect of heparin and/or antithrombin III in a model of disseminated intravascular coagulation induced by endotoxin in rabbits].
Gómez C; Páramo JA; Rocha E
Sangre (Barc); 1992 Feb; 37(1):5-10. PubMed ID: 1585238
[TBL] [Abstract][Full Text] [Related]
33. The suprapharmacologic dosing of antithrombin concentrate for Staphylococcus aureus-induced disseminated intravascular coagulation in guinea pigs: substantial reduction in mortality and morbidity.
Kessler CM; Tang Z; Jacobs HM; Szymanski LM
Blood; 1997 Jun; 89(12):4393-401. PubMed ID: 9192763
[TBL] [Abstract][Full Text] [Related]
34. Clinical experience with antithrombin III concentrate in treatment of congenital and acquired deficiency of antithrombin. The Antithrombin III Study Group.
Schwartz RS; Bauer KA; Rosenberg RD; Kavanaugh EJ; Davies DC; Bogdanoff DA
Am J Med; 1989 Sep; 87(3B):53S-60S. PubMed ID: 2679072
[TBL] [Abstract][Full Text] [Related]
35. Protection against disseminated intravascular coagulation and death by antithrombin-III in the Escherichia coli endotoxemic rat.
Emerson TE; Fournel MA; Leach WJ; Redens TB
Circ Shock; 1987; 21(1):1-13. PubMed ID: 3545529
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis and stage-related treatment of disseminated intravascular coagulation in meningococcal infections.
Mertens R; Peschgens T; Granzen B; Heimann G
Klin Padiatr; 1999; 211(2):65-9. PubMed ID: 10407813
[TBL] [Abstract][Full Text] [Related]
37. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.
Levi M; Toh CH; Thachil J; Watson HG
Br J Haematol; 2009 Apr; 145(1):24-33. PubMed ID: 19222477
[TBL] [Abstract][Full Text] [Related]
38. First visualization of circulating neutrophil extracellular traps using cell fluorescence during human septic shock-induced disseminated intravascular coagulation.
Stiel L; Mayeur-Rousse C; Helms J; Meziani F; Mauvieux L
Thromb Res; 2019 Nov; 183():153-158. PubMed ID: 31678710
[TBL] [Abstract][Full Text] [Related]
39. Thromboelastometry as a supplementary tool for evaluation of hemostasis in severe sepsis and septic shock.
Andersen MG; Hvas CL; Tønnesen E; Hvas AM
Acta Anaesthesiol Scand; 2014 May; 58(5):525-33. PubMed ID: 24580049
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and bleeding risk of antithrombin supplementation in septic disseminated intravascular coagulation: a secondary survey.
Iba T; Saitoh D; Wada H; Asakura H
Crit Care; 2014 Sep; 18(5):497. PubMed ID: 25220851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
